Podcasts about diagnostic

When a doctor hands your child a diagnosis, it can be a relief - finally, an explanation for their behavior! But sociologist Dr. Allan Horwitz has spent decades studying how psychiatric diagnoses are made, and what he's found raises serious questions about how much weight that label should carry. In this episode, Dr. Horwitz walks through how the Diagnostic and Statistical Manual (DSM) - the manual that defines every mental health diagnosis - was built less on scientific research than on professional politics, institutional pressure, and the practical needs of insurance companies.  He traces how depression went from a diagnosis given to a small fraction of the population to one of the most common diagnoses in the world, and explains exactly what happened to reliability when the DSM-5 was tested in real clinical conditions.  He also looks at how the same behaviors get labeled very differently depending on a child's age, race, class, and cultural background - and why that matters for every parent trying to figure out whether a diagnosis is actually helping their child. This episode won't tell you to reject diagnosis outright. But it will give you the critical knowledge to ask better questions when a label is offered for your child. Questions This Episode Will Answer What is the DSM and why does it matter for my child?  The DSM is the manual psychiatrists and psychologists use to diagnose every mental health condition. It determines what insurance will cover, what services your child can access, and what label follows them through school and into treatment. Who created the DSM and who controls it?  The American Psychiatric Association publishes the DSM, but its diagnostic criteria were largely shaped by a small group of people - predominantly white men with ties to pharmaceutical companies - whose process looked more like sausage-making than science. Why is DSM-5 criticized by researchers?  Field trials for DSM-5 showed reliability had actually declined from earlier editions. For some of the most common diagnoses, including major depression and generalized anxiety, agreement between clinicians was barely better than chance. Is a psychiatric diagnosis actually reliable?  Reliability means two different clinicians would give the same patient the same diagnosis. Research on the DSM-5 shows this is far less consistent than most parents assume - and a reliable diagnosis still isn't necessarily a correct one. Are children being overdiagnosed with mental health conditions?  Research shows that the youngest children in a classroom are significantly more likely to receive a psychiatric diagnosis than their older classmates, especially for ADHD - suggesting that what's being measured is developmental maturity, not a mental disorder. Does the DSM apply equally to children from different cultural backgrounds?  The DSM was built on a Euro-centric framework, and critics argue it pathologizes behaviors that are normal or valued in many Global Majority cultures. This has real consequences for how children from different backgrounds get diagnosed and treated. Why do mental health diagnoses focus on the individual instead of their circumstances?  The DSM is deliberately designed to identify disorders within a person rather than look at the conditions around them. It makes sense that a person going through a relationship breakup might feel sad, angry, and/or uncertain about the future.  That doesn't mean they're ‘depressed.'  Dr. Horwitz explains what that choice costs - and who pays the most. What You'll Learn in This Episode Why diagnosis serves the psychiatric profession and the insurance system in ways that don't always help the person being diagnosedHow the shift from psychoanalysis to the DSM-3 in 1980 dramatically expanded who could be diagnosed with depression - and why that shift was driven by professional rivalry, not new scienceWhat reliability and validity actually mean in psychiatric diagnosis, and why the numbers from DSM-5 field trials alarmed even people inside the systemHow the people who built the DSM criteria handled disagreements - and why the process Dr. Horwitz describes is so different from what most parents imagineWhy a child's birthdate relative to their classmates can predict their likelihood of receiving a psychiatric diagnosisHow socioeconomic status shapes not just whether a child gets diagnosed, but when they take their medication and whyWhat the removal of the bereavement exclusion in DSM-5 tells us about the direction the system is headingWhy the same behaviors that get a child diagnosed with ADHD in the US might get that child's family into therapy in the UK insteadWhat Dr. Horwitz thinks would actually make a difference for children's mental health - and why the most effective interventions are rarely the ones being offered Your Triggers Aren't a Diagnosis. But They're Worth Understanding. This episode makes the case that the mental health system focuses on only what's happening inside a person instead of looking at the broader circumstances around them - mostly to sell us more drugs.  In reality, our struggles are a combination of the challenges we've experienced in the past (and how we've learned to handle them), and our situation today.  We have to see both pieces to make sense of where we've been, and learn new tools for what's happening now. When your child's behavior sends you into a reaction you regret later, a diagnosis or prescription may not help as much as understanding what's underneath that reaction and where it came from.  That's exactly what the Taming Your Triggers workshop is built to help you do. In 10 weeks, you'll learn why you react the way you do, how to meet your own needs so you have more capacity for your kids, and how to respond from your values instead of your history. Enrollment is only open for a couple more days, until midnight Pacific on Wednesday, March 4. Click the banner to learn more Jump to highlights: 02:14 Introduction to today's episode 03:44 Why do we diagnose mental illness, and whose interests does the diagnostic system serve? Dr. Allan Horwitz explains that diagnoses maintain psychiatry's legitimacy and prestige as a medical profession, regardless of the knowledge behind each diagnosis. 05:10 Patients now often expect specific diagnoses before treatment even begins. 14:27 People experiencing sadness from job loss or relationship endings can benefit from medication, but to get prescriptions, you need a diagnosis of a disorder, even when the response is completely expectable given the circumstances. 15:39 The DSM locates suffering within individuals rather than examining broader social circumstances. 19:00 Wrapping up. 21:25 An open invitation to join the Parenting Membership.

Dr. Pamela Keel is Distinguished Research Professor in the Department of Psychology, Florida State University and the 2025-2026 Robert O. Lawton Distinguished Professor at Florida State University – the highest honor FSU faculty can award.  She directs the Eating Behaviors Research Clinic, co-directs the NIMH-funded Integrated Clinical Neuroscience Training Program, and leads efforts to enhance faculty recruitment and mentorship at Florida State University and has attracted over $55 million in external funding to FSU since joining their faculty in 2008. Her NIH-funded research examines the nosology, biology, epidemiology, and longitudinal course of eating disorders, and she has over 250 peer-reviewed journal articles and authored four books. Dr. Keel identified Purging Disorder as a new disorder of eating by revealing its clinically significant impact on the lives of those with the condition and demonstrating distinct postprandial gut peptide responses linked to purging in the absence of binge eating.  Her groundbreaking work contributed to Purging Disorder's inclusion in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Dr. Keel was honored with the AED Leadership Award in Research for the global impact of her work identifying Purging Disorder as a life-threatening illness affecting 1 in 50 women worldwide person does not.   We discuss topics including: Understanding the long-term outcome for bulimia nervosa (one person gets better and one person does not) Discussing what is weight suppression? Hormones including Leptin and Glucagon Peptide 1 (GLP-1) What happens when GLP-1 is released? What does lower leptin levels mean?   SHOW NOTES: https://www.cambridge.org/core/journals/psychological-medicine/article/test-of-a-biobehavioral-model-linking-weight-suppression-to-bingeeating-severity-via-leptin-and-glucagonlike-peptide-1-in-bulimia-nervosa-and-related-syndromes-in-women/C00119BEADF52EE75A53F7D675E9648A https://eatingbehaviorskee.wixsite.com/mysite https://www.cambridge.org/core/journals/psychological-medicine/article/test-of-a-biobehavioral-model-linking-weight-suppression-to-bingeeating-severity-via-leptin-and-glucagonlike-peptide-1-in-bulimia-nervosa-and-related-syndromes-in-women/C00119BEADF52EE75A53F7D675E9648A ___________________________________ If you have any questions regarding the topics discussed on this podcast, please reach out to Robyn directly via email: rlgrd@askaboutfood.com You can also connect with Robyn on social media by following her on Facebook, Instagram, Twitter, and LinkedIn. If you enjoyed this podcast, please leave a review on iTunes and subscribe. Visit Robyn's private practice website where you can subscribe to her free monthly insight newsletter, and receive your FREE GUIDE "Maximizing Your Time with Those Struggling with an Eating Disorder". Your Recovery Resource, Robyn's new online course for navigating your loved one's eating disorder, is available now! For more information on Robyn's book "The Eating Disorder Trap", please visit the Official "The Eating Disorder Trap" Website. "The Eating Disorder Trap" is also available for purchase on Amazon.

Dr. Centor discusses the diagnosis of Alzheimer disease with Dr. Gayatri Devi.

The future of optometry is being shaped in real time. Clinical scope continues to expand. Diagnostic technology grows more advanced. Patients expect greater access and clarity. Business models are evolving. Private equity is entering the conversation. Leadership opportunities are becoming more visible.

In this episode, Dr. Carrie Harmon (University of Florida), Dr. Matt Bertone (North Carolina State University), Dr. Alicyn Smart (University of Maine), and Dr. Peng Tian (University of Missouri) join host Matt Kasson to discuss the history and importance of National Plant Diagnostic Network, their various roles in the NPDN and the regional diagnostic networks, and their responsibilities as Directors of their University's Plant Disease and Pest Diagnostic Clinics. They also discuss some of the misconceptions of diagnostics and share some of the craziest samples they've encountered. *Show Notes * NPDN Website: https://www.npdn.org/ Dr. Carrie Harmon's University profile: https://plantpath.ifas.ufl.edu/people/faculty-pages/carrie-harmon/ UF/IFAS Plant Diagnostic Center: https://plantpath.ifas.ufl.edu/extension/plant-diagnostic-center/ Dr. Matt Bertone's University profile: https://www.ces.ncsu.edu/profile/matt-bertone/ NC State Plant Disease and Insect Clinic: https://pdic.ces.ncsu.edu/ Dr. Alicyn Smart's University profile: https://extension.umaine.edu/about/staff-directory/alicyn-smart/ The University of Maine Plant Disease Diagnostic Lab: https://extension.umaine.edu/ipm/plant-disease/ Dr. Peng Tian's University profile: https://cafnr.missouri.edu/directory/peng-tian-phd/ University of Missouri Plant Diagnostic Clinic: https://extension.missouri.edu/programs/plant-diagnostic-clinic This episode is produced by Association Briefings. Special Guests: Peng Tian, Alicyn Smart, Carrie Harmon, and Matt Bertone.

In this episode, Lillian Erdahl, MD, FACS, is joined by Jessica Liu, MD, MS, MPH, from the Department of Surgery, Harbor UCLA Medical Center. They discuss Dr Liu's recent article, “Identifying Diagnostic Gaps and Mitigation Strategies for Older Adult Emergency General Surgery Patients: A Scoping Review,” in which the authors identified the current diagnostic issues, clinical tools, and clinician feedback strategies in the older adult emergency general surgery (EGS) setting. While challenges unique to older adults exist, variability in the use of tools to improve identification of older adult conditions in EGS and gaps in feedback to improve diagnosis remain.   Disclosure Information: Drs Erdahl and Liu have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Liu, Jessica K MD, MS, MPH; Peters, Xane D MD, MS; Remer, Sarah L MD; Beestrum, Molly MLIS; Cooper, Zara MD, FACS, MPH; Russell, Marcia M MD, FACS; Hall, Bruce L MD, FACS, PhD; Ko, Clifford Y MD, FACS, MSHS, MS. Identifying Diagnostic Gaps and Mitigation Strategies for Older Adult Emergency General Surgery Patients: A Scoping Review. Journal of the American College of Surgeons 241(5):p 904-916, November 2025. | DOI: 10.1097/XCS.0000000000001480   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord   Copyright © 2026 by the American College of Surgeons (ACS). All rights reserved.   The contents of these materials may be cited in academic publications but otherwise may not be reproduced, disseminated, or transmitted in any form by any means without the express written permission of ACS. These materials may not be resold nor used to create revenue-generating content by any entity other than the ACS without the express written permission of the ACS. The contents of these materials are strictly prohibited from being uploaded, shared, or incorporated in any third-party applications, platforms, software, or websites without prior written authorization from the ACS. This restriction explicitly includes, but is not limited to, the integration of ACS content into tools leveraging artificial intelligence (AI), machine learning, large language models, or generative AI technologies and infrastructures. 

~ Téléchargez notre guide gratuit pour réussir votre investissement locatif ! ~

Growth often begins with a simple question: What can I do better? For Courtney Shearer, the answer was tracking engagement, not just understanding. This insight led her to transform her classroom through diagnostic teaching—collecting real-time data, implementing reflection routines, and shifting ownership of learning to her students. “I wanted to know that students were being heard, being challenged, but really being seen,” she says.In this episode of Unpacking Education, fourth-grade dual language teacher and AVID Certified Educator Courtney Shearer takes us inside her journey with diagnostic teaching. Her experience provided her with the tools, collaboration, and support to reframe challenges as opportunities. From tracking hand signals and student talk time to encouraging metacognitive conversations, Courtney models what it means to reflect with purpose. Her message to fellow educators: start small, plan for joy, and celebrate both student and teacher wins along the way.Visit AVID Open Access to learn more.

When a child is critically ill and answers are elusive, every day can feel like an eternity. This week on Tomorrow's Cure from Mayo Clinic, host Cathy Wurzer talks with pediatric geneticist Whitney Thompson, M.D., from Mayo Clinic, genomic medicine pioneer Stephen Kingsmore, M.D., DSc, from Rady Children's Institute for Genomic Medicine, and Sean George, Ph.D., CEO of Inflection Medicine, about how rapid whole genome sequencing is transforming care for the youngest patients. Together, they explore how clinicians are shortening the “diagnostic odyssey,” pairing sequencing with artificial intelligence to identify potential treatments, and redefining what is possible for rare diseases through programs like Mayo Clinic Children's BabyFORce. You will also hear powerful patient stories, including children whose lives changed after a genomic diagnosis opened the door to targeted therapies, and a candid discussion about cost, access, and ethics as this technology moves toward wider adoption. Tune in to learn how today's breakthroughs in pediatric genomics could shape the future of medicine for all of us. How to listen and stay connected:• Subscribe to Tomorrow's Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic's experts—subscribe to Mayo Clinic's newsletter for free today: ⁠https://mayocl.in/3EcNPNc⁠ Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/⁠Follow • Mayo Clinic on Instagram: ⁠https://www.instagram.com/mayoclinic/⁠Follow • Mayo Clinic on X (formerly Twitter): ⁠https://x.com/MayoClinic⁠Follow • Mayo Clinic on Threads: ⁠https://www.threads.net/@mayoclinic

Toi aussi, il t'est déjà arriver de te figer, de te sentir destabilisé·e face à certaines questions ou remarques qui t'ont remis·e en doute depuis que tu vis avec une maladie chronique ou un handicap Invisible ?

SummaryThis episode features a lively discussion on Olympic hockey, healthcare compliance, and the pitfalls of diagnostic coding. The hosts share insights on how practices often manipulate diagnoses for payment, the importance of proper documentation, and the impact of payer policies on clinical decisions.TopicsDiagnostic coding manipulationHealthcare audits and complianceImpact of payer policies on clinical decisions

Furf and Monty are back with another Pulm PEEPs Pearls episode. The topic of today’s discussion is an often discussed, but often misunderstood, test; the methacholine challenge. They’ll review when to utilize this test, how it should be performed, and the appropriate interpretation. Contributors This episode was prepared with research by Pulm PEEPs Associate Editor George Doumat. Dustin Latimer, another Pulm PEEPs Associate Editor, assisted with audio and video editing. Key Learning Points What the Test Measures Methacholine challenge is a direct bronchial provocation test of airway hyperresponsiveness (AHR), a core physiologic feature of asthma. Anyone will bronchoconstrict at high enough concentrations — the test looks for an abnormal threshold. The key endpoint is the PC20: the methacholine concentration causing a 20% fall in FEV1. Abnormal in adults: PC20 ≤ 8–16 mg/mL Test Performance Meta-analyses: pooled sensitivity ~60%, specificity ~90%. Real-world cohorts: sensitivity 55–62%, specificity 56–100% (varies by population, protocol, and threshold used). Not a standalone yes/no test — best used as part of a broader diagnostic pathway. Where It Fits in the Asthma Workup The test belongs in a stepwise approach: Step 1: Spirometry + bronchodilator response Step 2: Add FeNO and/or peak flow variability (if available) Step 3: If the picture is still unclear → methacholine challenge It is most useful for symptomatic patients with normal spirometry and no bronchodilator reversibility. Given its cost, mild risk, and discomfort, it should not be a first-line test — most asthma diagnoses do not require it. Technique and Medication Prep Technique ERS guidelines favor tidal breathing over deep inspiratory maneuvers. Deep breaths can be bronchoprotective and blunt the response, reducing sensitivity — especially in mild or well-controlled asthma. Medication Washout (to Avoid False Negatives) Medication ClassWashout PeriodShort-acting beta-agonists (SABA)≥ 6 hoursLong-acting beta-agonists (LABA)~24 hoursUltra-long-acting beta-agonists~48 hoursShort-acting anticholinergics (e.g., ipratropium)~12 hoursLong-acting muscarinic antagonists (LAMA, e.g., tiotropium)7 days Inhaled corticosteroids, leukotriene blockers, and antihistamines do not significantly affect the test acutely — continue these. Withdrawing ICS also carries its own risk for asthma patients. Practical tip: Spell out exactly what to hold and when — for both the patient and the PFT lab — at the time the test is ordered. Interpreting Results Negative Test (PC20 > 16 mg/mL) Very high negative predictive value in symptomatic adults. Makes current asthma quite unlikely (assuming proper test conduct). This is the test’s greatest strength: it is an excellent rule-out test. Positive Test (PC20 ≤ 8–16 mg/mL) More nuanced — airway hyperresponsiveness is not unique to asthma. Can be positive in: chronic cough, allergic rhinitis, COPD, and even some healthy asymptomatic individuals. A positive result raises probability but must be interpreted alongside the clinical story, variable respiratory symptoms, peak flow variability, FeNO, and ICS response. Safety and Risks Overall, the test is quite safe; significant adverse effects are rare. Temporary breathing discomfort is expected (bronchoconstriction is being induced). Severe bronchospasm is possible: A trained clinician should be available; SABA inhaler/nebulizer must be immediately on hand; a physician should be reachable in the facility. Contraindications / cautions: Avoid if FEV1 < 70% predicted or < 1–1.5 L (baseline obstruction greatly increases risk). Avoid within 3 months of an acute cardiac event (rare risk of cardiac events with unstable cardiac disease). Five Pearls — Quick Recap What it tests: Methacholine challenge is a direct test of AHR with high specificity but variable sensitivity — it belongs inside a diagnostic pathway, not as a standalone asthma test. When to use it: Most useful for symptomatic patients with normal spirometry and no bronchodilator response, after FeNO and peak flow variability have been considered. Technique and meds matter: Use tidal breathing protocol; respect washout intervals — especially the 7-day LAMA washout and 24–48 hour LABA window — to avoid false negatives. Safety: Generally safe, but can induce significant bronchoconstriction. Have a SABA available and avoid the test in patients with FEV1 < 70% predicted. Interpretation: A negative test (PC20 > 16 mg/mL) strongly argues against current asthma. A positive test raises probability but is not specific — interpret alongside the full clinical picture. References and Further Reading Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen; Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017 May 1;49(5):1601526. doi: 10.1183/13993003.01526-2016. PMID: 28461290. Lee, J., & Song, J. U. (2021). Diagnostic comparison of methacholine and mannitol bronchial challenge tests for identifying bronchial hyperresponsiveness in asthma: a systematic review and meta-analysis. Journal of Asthma, 58(7), 883–891. https://doi.org/10.1080/02770903.2020.1739704 Davis BE, Blais CM, Cockcroft DW. Methacholine challenge testing: comparative pharmacology. J Asthma Allergy. 2018 May 14;11:89-99. doi: 10.2147/JAA.S160607. PMID: 29785128; PMCID: PMC5957064.

In this episode of The Kula Ring, Jeff White and Carman Pirie welcome Maeve Ferguson, founder of Maeve Ferguson Consulting, to explore the power of diagnostic thought leadership. Maeve shares how sophisticated assessments go far beyond traditional quiz funnels, acting as intelligent routing engines that personalize messaging, qualify leads, and optimize sales conversations. From collapsing long B2B sales cycles to filtering out unqualified prospects, Maeve explains how diagnostics serve as both a value-delivery mechanism and a powerful data play. The conversation dives into lead classification systems, personalization at scale, and how agentic AI is transforming marketing infrastructure. For manufacturers navigating complex buying journeys, this episode reveals how diagnostic experiences can increase close rates, accelerate sales conversations, and build deeper trust with prospects.

Of all the industries AI will transform, Kira Radinsky believes chemistry and biology will change the most. Kira is the co-founder and CTO of Diagnostic Robotics, which uses AI to automate the administrative work that's crushing healthcare teams — so clinicians can actually focus on patients. She's also the co-founder of Mana.bio, where they're accelerating drug discovery by orders of magnitude.She'll tell you she's terrible in the lab. Not because she isn't brilliant, but because she can't pipette without killing the cells. So she's thrilled that thanks to her skills in data and AI she was able to realize her childhood dream of being a scientist: “I'm not trying to automate everything… Like when, when you say automate drug discovery, I'm not gonna discover everything. I just want to accelerate it, which comes back to my childhood dream: I just didn't want to do it myself. I just want AI to replace me as a scientist. That's it.”But this episode is about more than healthcare. It's about how to build systems that get smarter over time — feedback loops, causal inference, incentivizing algorithms to take risks, and knowing when to optimize for ROI instead of accuracy. Lessons that apply whether you're building in biotech or not.We cover:How growing up Jewish in Soviet Ukraine — and fleeing to Israel just before the Gulf War — shaped Kira's obsession with predicting the futureHow she built a system that successfully predicted real-world events, including Cuba's first cholera outbreak in Cuba in 130 yearsHow Mana.bio is using AI to build "rocketships" that deliver drugs to the right cells — and how they've done in three months what used to take 20 yearsWhy predictions are only valuable if there's something you can do about them — and why that makes healthcare an ideal field for AI How to incentivize algorithms to make bolder predictions (it's easy to predict there won't be an earthquake today; it's much harder to say there will be)Why causal inference is the most underrated tool in machine learning right nowHow healthcare AI can perpetuate racial bias — and what builders need to do differentlyNote: this interview originally aired in October 2024. Chapters:(01:44) - Why predictions are so important to Kira: lessons from fleeing Soviet-era Kyiv (05:10) - Building a prediction engine from 150 years of news (08:35) - How Kira predicted the Cuba cholera outbreak (09:50) - Returning to biology by way of data (12:50) - Predicting healthcare outcomes by finding your patient's twin (17:53) - The racial bias hiding in healthcare AI (19:15) - Building Mana.bio and accelerating drug discovery (24:33) - "In three months, what did what used to take 20 years" (31:44) - Builder tips: ROI, causal inference, and teaching algorithms to explore (35:07) - Planning: Where generative AI needs improve Links & Resources:Kira Radinsky on LinkedInDiagnostic RoboticsMana.bioSupport Future Around & Find OutGet the free newsletterAnd consider becoming a paid subscriber and help future proof this thing!Sponsor the show? Are you looking to reach an audience of senior technologists and decision-makers? Email me: dan@modernproductminds.com---Music by Jonathan Zalben

Selon l'OMS, la schizophrénie touche environ 23 millions de personnes dans le monde. Psychose caractérisée par la perte du contact avec la réalité et par des altérations du comportement, la schizophrénie est la maladie mentale chronique la plus fréquente. Les personnes atteintes sont souvent victimes d'une forte stigmatisation qui les pousse à s'isoler. Comment déconstruire les préjugés liés à cette maladie ? Quels sont les traitements existants ?   Si les réseaux sociaux et les médias traitent de plus en plus souvent des thématiques liées à la santé mentale, les préjugés et fausses croyances associées à certaines maladies psychiatriques, comme aux personnes atteintes, sont toujours bel et bien réels. Et parmi les maladies les plus stigmatisées, on retrouve la schizophrénie. Lutter contre les idées fausses  Schizophrène : adjectif utilisé dans le vocabulaire – notamment par la classe politique – pour dévaloriser, insulter…  La schizophrénie est une atteinte encore souvent associée à des comportements agressifs, alors que si une tendance à la violence peut s'exprimer, non seulement elle n'est pas systématique, mais elle est dans la plupart des cas dirigée contre les patients eux-mêmes. Dans certains contextes culturels, la schizophrénie est également assimilée à une malédiction, à un sort potentiellement transmissible...  Autant d'idées fausses qui vont isoler, ostraciser et accentuer les souffrances des personnes concernées comme de leur entourage. Autant de préjugés qui peuvent potentiellement retarder et entraver les prises en charge. Diagnostic et prise en charge précoce  La schizophrénie est une maladie grave, qui peut se manifester par des symptômes multiples : une déconnexion du réel, des émotions inappropriées à la situation. Les personnes concernées ne sont pas forcément conscientes de leur maladie et cette psychose est susceptible d'avoir, faute de prise en charge précoce et adaptée, d'importantes conséquences sur l'organisation du quotidien, le lien avec les autres, la poursuite des activités.  Les schizophrénies, dont on peut d'ailleurs parler au pluriel, en raison de la variété des symptômes d'une personne à l'autre, vont donc nécessiter une prise en charge personnalisée, et qui va évoluer dans le temps.  Avec : Dr Méja Andrianarisoa, psychiatre en libéral sur Paris centre, au cabinet CPPND (Cabinet de Psychiatrie et Psychothérapie Notre-Dame) Dr Cheikh Mohamed Fadel Gohi, psychiatre /addictologue, directeur central au Cabinet du ministre de la Santé en Mauritanie, chargé de la coordination du Programme National de Santé Mentale et de Lutte contre les Addictions. Un reportage de Charlie Dupiot. ► En fin d'émission, nous parlerons de la baisse annoncée de la contribution française au Fonds mondial de lutte contre le sida, la tuberculose et le paludisme, la promesse de don de l'État français s'élevant à 660 millions d'euros, soit un milliard d'euros en moins que lors de la période précédente. 9 associations de lutte contre ces maladies se sont réunies pour protester contre cette baisse. Interview de Marc Dixneuf, directeur général de AIDES.  Programmation musicale :  ► Kokoroko – Da du dah  ► Fabio Brazza, Vitao – Partido alto.    À lire aussiDécouvrez les 10 finalistes du Prix Découvertes RFI 2026, et votez !

Selon l'OMS, la schizophrénie touche environ 23 millions de personnes dans le monde. Psychose caractérisée par la perte du contact avec la réalité et par des altérations du comportement, la schizophrénie est la maladie mentale chronique la plus fréquente. Les personnes atteintes sont souvent victimes d'une forte stigmatisation qui les pousse à s'isoler. Comment déconstruire les préjugés liés à cette maladie ? Quels sont les traitements existants ?   Si les réseaux sociaux et les médias traitent de plus en plus souvent des thématiques liées à la santé mentale, les préjugés et fausses croyances associées à certaines maladies psychiatriques, comme aux personnes atteintes, sont toujours bel et bien réels. Et parmi les maladies les plus stigmatisées, on retrouve la schizophrénie. Lutter contre les idées fausses  Schizophrène : adjectif utilisé dans le vocabulaire – notamment par la classe politique – pour dévaloriser, insulter…  La schizophrénie est une atteinte encore souvent associée à des comportements agressifs, alors que si une tendance à la violence peut s'exprimer, non seulement elle n'est pas systématique, mais elle est dans la plupart des cas dirigée contre les patients eux-mêmes. Dans certains contextes culturels, la schizophrénie est également assimilée à une malédiction, à un sort potentiellement transmissible...  Autant d'idées fausses qui vont isoler, ostraciser et accentuer les souffrances des personnes concernées comme de leur entourage. Autant de préjugés qui peuvent potentiellement retarder et entraver les prises en charge. Diagnostic et prise en charge précoce  La schizophrénie est une maladie grave, qui peut se manifester par des symptômes multiples : une déconnexion du réel, des émotions inappropriées à la situation. Les personnes concernées ne sont pas forcément conscientes de leur maladie et cette psychose est susceptible d'avoir, faute de prise en charge précoce et adaptée, d'importantes conséquences sur l'organisation du quotidien, le lien avec les autres, la poursuite des activités.  Les schizophrénies, dont on peut d'ailleurs parler au pluriel, en raison de la variété des symptômes d'une personne à l'autre, vont donc nécessiter une prise en charge personnalisée, et qui va évoluer dans le temps.  Avec : Dr Méja Andrianarisoa, psychiatre en libéral sur Paris centre, au cabinet CPPND (Cabinet de Psychiatrie et Psychothérapie Notre-Dame) Dr Cheikh Mohamed Fadel Gohi, psychiatre /addictologue, directeur central au Cabinet du ministre de la Santé en Mauritanie, chargé de la coordination du Programme National de Santé Mentale et de Lutte contre les Addictions. Un reportage de Charlie Dupiot. ► En fin d'émission, nous parlerons de la baisse annoncée de la contribution française au Fonds mondial de lutte contre le sida, la tuberculose et le paludisme, la promesse de don de l'État français s'élevant à 660 millions d'euros, soit un milliard d'euros en moins que lors de la période précédente. 9 associations de lutte contre ces maladies se sont réunies pour protester contre cette baisse. Interview de Marc Dixneuf, directeur général de AIDES.  Programmation musicale :  ► Kokoroko – Da du dah  ► Fabio Brazza, Vitao – Partido alto.    À lire aussiDécouvrez les 10 finalistes du Prix Découvertes RFI 2026, et votez !

Despite major advances in our understanding of the biology of mental health disorders,  there's no blood test or brain scan that will confirm if you have depression, anxiety, PTSD, or any other psychiatric illness.  And yet, the American Psychiatric Association recently announced that it will be including biomarkers for mental conditions in the next edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM), which guides diagnosis and treatment of mental illness. So how close are we to pinpointing the biological markers of mental illness, and what does that mean for diagnosis? It's complicated.  Host Flora Lichtman untangles some of this science with psychiatry researcher John Krystal. Guest: Dr. John Krystal is a professor of psychiatry, neuroscience, and psychology at the Yale School of Medicine. Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this solo episode, Brad shares a few recent herd-health case studies from his dairy, highlighting the value of diagnostics and transparency.He walks through two calf losses—one at 60 days old and another at 9 months. Both animals had been treated for common issues but continued to decline. Necropsies revealed severe heart abnormalities in each case (thin, underdeveloped ventricles), pointing toward possible genetic or nutritional causes. The takeaway: without a necropsy, these would have remained unexplained losses.Brad also discusses a recent abortion in a dry cow. Diagnostic testing ruled out BVD and IBR and identified Citrobacter sp., an environmental organism found in manure, soil, and bedding that can contribute to abortions. He suspects environmental exposure in wintered dry cows may have played a role.Overall, the episode emphasizes investigating unexpected losses, using lab diagnostics, and learning from on-farm challenges as spring calving approaches.Questions, comments, scathing rebuttals? -> themoosroom@umn.edu or call 612-624-3610 and leave us a message!Linkedin -> The Moos RoomTwitter -> @UMNmoosroom and @UMNFarmSafetyFacebook -> @UMNDairyYouTube -> UMN Beef and Dairy and UMN Farm Safety and HealthInstagram -> @UMNWCROCDairyExtension WebsiteAgriAmerica Podcast Directory 

In Week 8 of our Follow Me series with Pastor Dave Mudd we dive deep into the "Up" rhythm of Jesus' life, exploring how true transformation begins with our private intimacy with the Father. Are you living to please God, or are you caught in the trap of people-pleasing and performance? Pastor Dave challenges us to move away from duty and guilt, discovering a life of delight through daily devotion. Learn how a heart aligned with God's will creates a "kingdom impact" that is courageous, consistent, and contagious. Watch to discover how spending time with God is the key to living the gospel in every area of your life.Key Takeaways:- Relationship Over Religion: Discover why obedience should flow from affection and delight rather than obligation, guilt, or fear.- The Power of Private Devotion: Understand why you cannot live to please God publicly if you do not meet with Him privately.- Overcoming People-Pleasing: Learn to identify and lay down the "silent rival" of seeking human approval so you can be a true servant of Christ.- Kingdom Impact: See how a life aligned with the Father naturally produces peace, courage, and spiritual authority that others can sense.- The Diagnostic of Devotion: Use a simple daily question—"What would please the Father today?"—to shift your reference point from horizontal to vertical.

In this episode of Podcast360, Norman Weinberg, MD, a retired primary care internist with over 40 years of experience, discusses the intricacies of managing physician behavior and diagnostic errors.

Le repos n'est pas une récompense, c'est un outil stratégique.Le 15 février 2026, mon corps a tiré la sonnette d'alarme pour la deuxième fois. Diagnostic : péricardite aiguë. Forcé à l'immobilité totale, j'ai dû confronter ce vide que nous fuyons tous en tant qu'entrepreneurs.Dans cet épisode, je te partage pourquoi la culture du "hustle" permanent est un mirage qui détruit ta clarté et ta performance. J'ai découvert que c'est précisément dans l'absence d'action que naissent les meilleures idées et les décisions stratégiques les plus puissantes.0:00 – Le choc : Deuxième péricardite en 5 ans. Marco revient sur l'événement qui l'a forcé à s'arrêter brutalement et le timing ironique avec ses 7 ans de sobriété.1:25 – La culture de l'occupation vs La performance réelle. Pourquoi nous glorifions le surmenage alors que les athlètes de haut niveau savent que la récupération fait partie de l'entraînement.2:10 – Les 3 leçons du repos forcé. Découverte du repos physique profond, de la clarté d'esprit organique et du recul stratégique sur son entreprise.5:28 – Ma nouvelle stratégie : La semaine de "Vide Intentionnel". Marco explique son plan de prendre une semaine de recul toutes les 8 semaines, sans mandats clients ni création de contenu.7:14 – Vaincre la peur de s'arrêter. Comment affronter les "Bitch Voices" qui nous disent qu'on va perdre notre momentum ou nos revenus.9:04 – Bâtir des systèmes pour être libre. L'importance de l'automatisation et de l'IA pour que le business tourne sans notre présence constante.

 In this episode, Neil Roy, MD, MBA, FACEP, CPE, Vice President of Diagnostic and Operative Services and Chief Medical Officer at Adventist HealthCare, shares how marketplace rounds, high risk discharge clinics, and remote monitoring cut length of stay by up to 15 percent and lowered readmissions below 10 percent, while strengthening physician engagement and preparing for AI driven patient flow innovation under Maryland's global budget model.

Fertility care is undergoing a significant shift as new diagnostic technologies offer deeper insight into reproductive health. OTO Fertility focuses on predicting the likelihood of IVF success before treatment begins, giving couples clarity at a stage where uncertainty has traditionally dominated the process. The system uses a wearable device that captures physiological signals and converts them into predictive metrics, offering a noninvasive method for understanding fertility readiness.The challenge addressed by this technology is substantial. IVF remains expensive, time‑consuming, and emotionally demanding, yet the success rate for a single transfer remains low. Many couples undergo multiple cycles without clear guidance on their likelihood of success. By providing predictive insight before treatment, the system aims to reduce unnecessary cycles, lower financial burden, and support more informed decision‑making.Physiological Monitoring and Predictive ModelingThe OTO Fertility device performs medical‑grade ECG and EEG measurements, capturing data from multiple physiological systems. These include cardiac activity, central and autonomic nervous system responses, hormonal regulation patterns, and energy supply indicators. Dozens of body signals are synthesized into a set of metrics that correlate with fertility outcomes. These metrics are then combined into a single index that reflects the couple's overall fertility readiness.Both partners participate in the process, allowing the system to evaluate male and female factors independently and together. This dual‑side approach supports a more complete understanding of fertility challenges, including those that may not be detected through traditional testing. The system also supports natural conception by identifying physiological patterns that can be optimized without clinical intervention.Personalized Guidance Through AIOnce the fertility index is generated, the system provides personalized recommendations designed to improve physiological readiness. These recommendations are based on lifestyle factors that influence fertility, including activity levels, rest, recovery, nutrition, sleep, and stress management. The guidance is tailored to each individual and delivered through the accompanying application, creating a structured pathway for improvement.The use of AI allows the system to adapt recommendations as new data is collected. Daily measurements support continuous monitoring, enabling couples to track progress and understand how their bodies respond to changes. This dynamic approach contrasts with traditional fertility diagnostics, which often rely on static snapshots taken at a single point in time.Broader Fertility Insights and Lifecycle SupportThe technology also provides insight into previously unexplained fertility challenges. A significant portion of infertility cases fall into the unexplained category, where standard tests show no clear cause. By analyzing physiological patterns across multiple systems, the device offers a new layer of understanding that can help clarify these cases.The system extends beyond conception, offering support during pregnancy and postpartum. This continuity allows couples to remain engaged with their physiological health throughout the entire fertility journey. The solution is delivered in partnership with treating physicians and virtual clinics, integrating seamlessly into existing care pathways.ConclusionOTO Fertility introduces a predictive diagnostic system designed to improve IVF outcomes and support natural conception through physiological monitoring and AI‑driven guidance. By providing insight into fertility readiness, offering personalized recommendations, and addressing both partners' health, the system creates a more informed and supportive pathway for couples seeking to build their families. As fertility challenges continue to rise globally, technologies that deliver clarity, personalization, and noninvasive insight are becoming essential components of modern reproductive care.Interview by Don Baine, The Gadget Professor.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. Secure your connection and unlock a faster, safer internet by signing up for PureVPN today.

Fertility care is undergoing a significant shift as new diagnostic technologies offer deeper insight into reproductive health. OTO Fertility focuses on predicting the likelihood of IVF success before treatment begins, giving couples clarity at a stage where uncertainty has traditionally dominated the process. The system uses a wearable device that captures physiological signals and converts them into predictive metrics, offering a noninvasive method for understanding fertility readiness.The challenge addressed by this technology is substantial. IVF remains expensive, time‑consuming, and emotionally demanding, yet the success rate for a single transfer remains low. Many couples undergo multiple cycles without clear guidance on their likelihood of success. By providing predictive insight before treatment, the system aims to reduce unnecessary cycles, lower financial burden, and support more informed decision‑making.Physiological Monitoring and Predictive ModelingThe OTO Fertility device performs medical‑grade ECG and EEG measurements, capturing data from multiple physiological systems. These include cardiac activity, central and autonomic nervous system responses, hormonal regulation patterns, and energy supply indicators. Dozens of body signals are synthesized into a set of metrics that correlate with fertility outcomes. These metrics are then combined into a single index that reflects the couple's overall fertility readiness.Both partners participate in the process, allowing the system to evaluate male and female factors independently and together. This dual‑side approach supports a more complete understanding of fertility challenges, including those that may not be detected through traditional testing. The system also supports natural conception by identifying physiological patterns that can be optimized without clinical intervention.Personalized Guidance Through AIOnce the fertility index is generated, the system provides personalized recommendations designed to improve physiological readiness. These recommendations are based on lifestyle factors that influence fertility, including activity levels, rest, recovery, nutrition, sleep, and stress management. The guidance is tailored to each individual and delivered through the accompanying application, creating a structured pathway for improvement.The use of AI allows the system to adapt recommendations as new data is collected. Daily measurements support continuous monitoring, enabling couples to track progress and understand how their bodies respond to changes. This dynamic approach contrasts with traditional fertility diagnostics, which often rely on static snapshots taken at a single point in time.Broader Fertility Insights and Lifecycle SupportThe technology also provides insight into previously unexplained fertility challenges. A significant portion of infertility cases fall into the unexplained category, where standard tests show no clear cause. By analyzing physiological patterns across multiple systems, the device offers a new layer of understanding that can help clarify these cases.The system extends beyond conception, offering support during pregnancy and postpartum. This continuity allows couples to remain engaged with their physiological health throughout the entire fertility journey. The solution is delivered in partnership with treating physicians and virtual clinics, integrating seamlessly into existing care pathways.ConclusionOTO Fertility introduces a predictive diagnostic system designed to improve IVF outcomes and support natural conception through physiological monitoring and AI‑driven guidance. By providing insight into fertility readiness, offering personalized recommendations, and addressing both partners' health, the system creates a more informed and supportive pathway for couples seeking to build their families. As fertility challenges continue to rise globally, technologies that deliver clarity, personalization, and noninvasive insight are becoming essential components of modern reproductive care.Interview by Don Baine, The Gadget Professor.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. Secure your connection and unlock a faster, safer internet by signing up for PureVPN today.

Thanks to our Partners, NAPA TRACS, Today's Class, KUKUI, and Pit Crew Loyalty Watch Full Video Episode Host Carm Capriotto dives into the untapped power of Shop Management Systems (SMS) with business coach Dave Schedin and Ben Dexter, National Training Manager at NAPA TRACS. Together, they reveal how two often-overlooked tools, categories and canned jobs, can dramatically improve shop efficiency, consistency, and profitability. The conversation highlights how a smarter system setup leads to faster workflows, clearer data, and stronger decision-making. Key Topics Discussed Unlocking the Power of Categories: Dave Schedin explains the importance of tracking three core labor types: Diagnostic, Preventative Maintenance, and Repair. When categorized correctly, shop owners can pinpoint exactly where time and money are gained—or lost. Building the “Superhighway” to Faster Estimates: Schedin compares developing Canned Jobs to constructing a freeway: it takes an upfront investment of time, but once built, it enables rapid, efficient estimating. Professional Communication: Canned jobs help replace vague descriptions with clear, value-focused explanations. This allows newer advisors to communicate like seasoned professionals while ensuring consistent pricing, messaging, and storytelling across the shop. Turning Data into Profit: Ben Dexter reinforces the principle of “garbage in, garbage out”: without clean, organized data, shop owners are simply guessing. By mastering categories and canned jobs, shop owners can turn their management system into a powerful engine for clarity, consistency, and long-term profitability. Timestamps 00:00:00 – Introduction 00:03:15 – The Three Labor Categories (Diagnostic, PM, Repair) 00:05:45 – Creating Smart Warranty Categories 00:08:20 – Data Integrity: “Garbage In, Garbage Out” 00:14:15 – Canned Jobs & Professional Storytelling 00:16:30 – “Level 10” Jobs & Built-In Parts Triggers 00:18:00 – Reducing Advisor Cognitive Load 00:19:45 – Generic Jobs vs. Vehicle-Specific “Pro Jobs” 00:22:30 – Helping New Advisors Sound Like Pros 00:25:00 – Writing Complex Estimates in 2–3 Minutes 00:29:15 – The ROI: 15–20% Sales Growth Potential 00:31:00 – Building the Estimating “Superhighway” Dave Schedin, CompuTrek Automotive Management Systems. Dave's previous episodes HERE Ben Dexter, National Training Manager, NAPA TRACS. Find Ben's other episodes HERE Thanks to our Partner, NAPA TRACS NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the...

Pour l'épisode #334 je recevais Alexis Ducarouge. On en débrief avec Jean-Christophe.🎙️ Soutenez le podcast If This Then Dev ! 🎙️ Chaque contribution aide à maintenir et améliorer nos épisodes. Cliquez ici pour nous soutenir sur Tipeee 🙏Archives | Site | Boutique | TikTok | Discord | Twitter | LinkedIn | Instagram | Youtube | Twitch | Job Board |Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

In this episode of I Thought You'd Like to Know, Marcus Peter of Ave Maria Radio Interviews Stephen Rouhana on his book The King and Queen are Naked: Establishment Failures based on Scientific, Medical, and Psychiatric Research on “Gender Dysphoria” (February 9, 2026)This book is the result of analysis of the literature on Gender Dysphoria published in journals of psychology, psychiatry, and medicine, and in other relevant publications.In part one, Dr. Rouhana starts from basic definitions and leads the reader through the maze of articles and opinions on the subject to the unavoidable conclusion that the gender identity issues underlying Gender Dysphoria do constitute a mental disorder. He examines how the current recommendations in the Diagnostic and Statistics Manual of Mental Disorders (DSM) published by the American Psychiatric Association have been intentionally written to mislead the general public and medical insurance companies.In part two, Dr. Rouhana explores what ethical treatments are, and are not, for Gender Dysphoria given the conclusions from part one.In part three, he explores what the Catholic Church has taught on this topic, from the perspective of faith and philosophy. Each part ends with proposed actions to truly help those suffering with this issue.The King and Queen are Naked: Establishment Failures based on Scientific, Medical, and Psychiatric Research on “Gender Dysphoria” by Stephen W. Rouhana, Ph.D. | En Route Books and Media

Au moment où le ministre de la Ville et du Logement, Vincent Jeanbrun vient de défendre au Sénat la proposition de loi (PPL) portée sénatrice centriste du Pas-de-Calais Amel Gacquerre visant à clarifier les obligations de rénovation énergétique des logements et à sécuriser leur application en copropriété, les réactions des parlementaires experts sur le sujet commencent à réagir. Car le risque selon Vincent Jeanbrun, interrogé sur Public Sénat le mardi 17 février 2026 , « c'est que 700 000 logements sortent du parc locatif à cause d'un Diagnostic de performance énergétique (DPE) pas assez bon. » L'idée du ministre ? « C'est de continuer à louer avec l'engagement de rénover le bien en trois en ou cinq ans », explique-t-il sur la chaîne parlementaire. De son côté, le groupe politique Rassemblement National discret jusqu'à l'an dernier sur la rénovation énergétique monte au créneau par la voix de Frédéric Falcon, député de l'Aude (circonscription de Narbonne) et ancien professionnel du secteur vient justement de rencontrer justement le ministre du Logement pour aborder avec lui les problématiques autour du DPE et lui faire de ses inquiétudes sur cette proposition de loi Gacquerre. « De base au RN qui a déjà proposé de supprimer MaPrimeRénov' et de la remplacer par des prêts aux ménages à taux zéro, nous sommes opposés aux contraintes du DPE pour la location des logements, affirme le monsieur Logement du parti de Marine Le Pen. Instaurer un calendrier depuis le 1er janvier 2025 a toujours été inconcevable et cela créé 75 % d'annonces en moins de trois ans… » Frédéric Falcon s'interroge : « Cette PPL fait appel à un juge le temps des travaux et qu'est-ce qui se passe après s'il y a une intervention du juge qui a baissé le loyer et malgré les travaux ? Le propriétaire-bailleur alors sera condamné à avoir un loyer minoré et cette situation ouvre à plein de contentieux. » Autre risque selon lui : « Cela va tétaniser les propriétaires qui ont souvent un à deux logements. On lance les warning ! »

Dr. Halley Alexander and Dr. Alissa M. D'Gama discuss genetic testing for infantile epilepsies.  Show citation:  Nguyen JNH, Lachgar-Ruiz M, Higginbotham EJ, et al. Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy. Neurology. 2026;106(6):e214645. doi:10.1212/WNL.0000000000214645  Show transcript:  Dr. Halley Alexander:  Hi, this is Halley Alexander with today's Neurology Minute, and I'm here with Dr. Alissa D'Gama from Boston Children's Hospital and Harvard Medical School, and we just finished recording a full-length podcast about some exciting new work in genetic testing for infantile onset epilepsies. Alissa, can you tell us what you found briefly and why it's important for neurology care? Dr. Alissa D'Gama:  Infantile epilepsies are relatively common, and they're associated with substantial burden of disease, and we know that identifying underlying genetic causes can impact clinical care. It's important for emerging precision therapies. But even after genome sequencing, which is the most comprehensive clinical genetic testing currently available, most infants remain genetically unsolved. And so what we did was take that genome sequencing data and reanalyze it for a cohort of infants who had unexplained non-acquired epilepsy and non-diagnostic genome sequencing, and in about 5% of cases, our reanalysis was able to identify a genetic diagnosis, and all of these diagnoses had impact on clinical care for their infants and their families. In some cases, we could incorporate new information, either new clinical information about the patient or new scientific methods or information about disease associations, and in other cases, we were able to incorporate new analysis methods to identify variants. And so our findings suggest that implementing reanalysis for infants or any individual with epilepsy within a year or two of non-diagnostic testing may be useful. Dr. Halley Alexander:  Thank you so much, and you can find a lot more details by listening to the full-length podcast, which is available now on the Neurology podcast, and you can find the full article in the March 10th issue of Neurology or online at neurology.org. As always, thanks for tuning in for today's Neurology Minute. 

In this episode of the Health Coach Academy Podcast, we sit down with Maeve Ferguson, former Big Four consultant turned online business strategist, to unpack one of the most underrated but powerful marketing tools in the coaching industry: diagnostic quizzes and score-based assessments. Maeve shares how health coaches, consultants, and experts can transform their intellectual property into scalable lead-qualification systems that attract high-quality, high-ticket clients — without wasting hours on unqualified discovery calls. If you've ever wondered how quizzes actually work behind the scenes — or why some coaches quietly scale to multi-six-figure and seven-figure businesses — this episode pulls back the curtain.

În Episodul 167 din Thinking Made Visible am stat de vorbă cu Adriana Mocan despre identitate, disciplină și ce se întâmplă atunci când viața îți schimbă complet ritmul.Antreprenor, mamă, mereu în mișcare, genul de om care funcționează pe structură, plan și soluții. O minte pragmatică, orientată spre construcție.În 2019, într-o dimineață la ora 5, corpul ei nu a mai răspuns - diagnosticul a fost scleroză multiplă, formă rară și agresivă. Au urmat luni de investigații, căutări, întrebări, second opinions, studii citite și un plan construit pas cu pas. Adriana a ales să facă autotransplant de celule stem, într-un context dificil, iar recuperarea a însemnat ani de muncă susținută, disciplină și reconstrucție zilnică.Ne-am dorit ca această conversaţie să fie despre responsabilitate, cum transformi frica în structură și despre cum identitatea ta se reconfigurează atunci când standardele rămân aceleași, iar corpul are alt ritm.Intro (00:00)Cine era Adriana, în 2019? (04:10)Care a fost momentul din 2019 care i-a schimbat viața (04:58)Diagnostic scleroză multiplă (09:32)A plecat singură în Rusia pentru transplant (12:57)Primul an după transplant (27:51)„Cine sunt eu acum?” (33:22)Adriana care mută munții și Willness (36:43)Mesaj pentru persoanele cu acest diagnostic (41:40)Mesaj pentru persoanele din familia celui diagnosticat cu scleroză multiplă (47:20)Conferință în SUA - invitată ca speaker (53:19)Pacienții din România (55:49)Viziunea ei pentru Willness (57:18)Outro (1:09:13)

Are you up to date on HER2 testing best practices? Join our expert panel and discover the critical updates that guide treatment selection. Credit available for this activity expires: 2/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-her2-spectrum-breast-cancer-evolving-diagnostic-2026a10004ea?ecd=bdc_podcast_libsyn_mscpedu

Episode 5: The Polymathic Crime/Murder Board | A Diagnostic for an Age Addicted to Verdicts . What if our biggest threat to justice isn't corruption or ignorance, but our addiction to certainty? . In an age of instant outrage, viral accusations, and premature conclusions, we confuse speed with truth and emotional relief with accountability. Verdicts arrive long before understanding does, and they feel righteous, even when they're wrong. . In this episode of The Polymathic Perspective, we step into a radically different posture. Not a verdict. A diagnostic. . Using the logic of an FBI murder board, this episode examines why the human nervous system rushes to conclusions, how identity hijacks inquiry, and why simplifying harm into heroes and villains so often protects the systems that produce it. . You'll explore: Why certainty is neurologically soothing, and epistemically dangerous How the Central Park Five exposed what happens when narrative speed outruns investigative discipline Why harm often looks like alignment, not deviation How proxy wars reveal invisible beneficiaries and misplaced accountability Why real change always carries cost, and why cost is the only reliable evidence How the Epstein files function as an epistemic stress test, not a list of verdicts . This episode will frustrate anyone looking for outrage, moral shortcuts, or clean villains. It's designed for listeners willing to sit with uncertainty long enough for truth to survive pressure. Because justice that can't withstand scrutiny isn't justice at all... It's theater. . If you're ready to trade certainty for coherence, and outrage for accuracy, this episode will change how you listen to everything that comes next. About The Polymathic Perspective Podcast . The Polymathic Perspective is a weekly practice for integrative thinkers, leaders, and curious minds who refuse to collapse complexity into comforting lies. Each episode examines how meaning, identity, incentives, and systems interact beneath the stories we're told. This is not a podcast for conclusions. It's a podcast for diagnostic clarity.

By David Stephen who looks at biomarkers in this article. Will there ever be a biological test for human intelligence, to explore how to improve it in the age of AI? Like, would it ever be possible to test a human being for intelligence by some biological factor, and how to make it competitive against AI? The same question applies to mental disorders. Would there ever be biological tests, to know what therapies would work? These, at least for mental disorders, is what the American Psychiatric Association is seeking. Biomarkers for Psychiatry, Human Intelligence There is a recent [January 28, 2026] press release, APA Releases Roadmap for the Future of the DSM, stating that, "The American Psychiatric Association (APA) has released a series of papers offering a proposed roadmap for the future of the Diagnostic and Statistical Manual of Mental Disorders (DSM). The five papers, including the Initial Strategy for the Future of the DSM and four accompanying commentaries, are the result of the committee's year of structured debate and consideration of long-standing critiques and rapid scientific advances. They propose a forward-looking model for the evolution of the DSM. They also suggest changing the name from Diagnostic and Statistical Manual to Diagnostic and Scientific Manual to better reflect its scientific and global scope. The four accompanying papers address structure and dimensions of the DSM; the role of biomarkers and biological factors in diagnosis; vision for incorporating socioeconomic, cultural and environmental determinants of health and intersectionality; and the role of functioning and quality of life in psychiatric diagnosis." Conceptual Biomarkers and Theoretical Biological Factors for Psychiatric and Intelligence Nosology What are the options for biomarkers in the brain for mental disorders? Would they be different or similar to those for human intelligence? What are the universal components in the brain, for functions of human life and experiences? Can a model be developed on these components and their mechanisms, first to explain labels and next to scope out biomarkers? The problem before psychiatry is not just the distance to developing tests but to even describe what is happening in the brain for the labels of conditions. Mood disorders have several descriptions. But what are their components in the brain and the course of their actions. Answering these questions can put conditions in perspective as parallels are sought, before adventuring into biomarkers development. The same applies to human intelligence. Now, artificial intelligence is in an intense acceleration. There are valuable labor tasks that will be lost due to AI. And, because intelligence is the last frontier of superiority for humanity among organisms, it will be important to seek to map it, and explore it for problem-solving. This is the postulation in Conceptual Biomarkers and Theoretical Biological Factors for Psychiatric and Intelligence Nosology. The options are electrical and chemical signals as the components of functions in the brain. It states that neurons are conduits or bridges that signals use to carry out functions. It also states that signals are in sets in cluster of neurons. It is possible to use signals, conceptually, to explain and display all disorders in the DSM. It is also possible to use them to develop, explain, and display the two main types of human intelligence [improvement and operational], to ensure that options are broadened towards survival in the age of AI. This seminal work on conceptual brain science could be completed by August, 2026, moving psychiatry and intelligence forward, as well as neurology. David Stephen currently does research in conceptual brain science with focus on the electrical and chemical configurators for how they mechanize the human mind with implications for mental health, disorders, neurotechnology, consciousness, learning, artificial intelligence and nurture. He was a visiting scholar in m...

Boala e efortul funcțiilor vitale de a elibera organismul din starea provocată de încălcarea legilor sănătății. Chiar în fața cancerului, există perspectivă spirituală. Dumnezeu ne cheamă să privim cauza, nu doar efectele. Suferința separă zgura de aurul caracterului creștin, curățind metalul prețios. Citește acest devoțional și multe alte meditații biblice pehttps://devotionale.ro#devotionale #devotionaleaudio

Summary In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar and Dr. Peter Lio discuss significant advancements in dermatology, including the recent approval of an ICD 10 code for topical steroid withdrawal, the exploration of botanicals in skin treatment, and the emerging understanding of the gut-skin connection. They also delve into the role of GLP medications in managing skin conditions and the exciting future developments in dermatology, particularly in the treatment of atopic dermatitis. Read the referenced documents at the following sites: - Ancient botanicals and the skin: Defining dermatologic ethnophytoconvergence as a translational framework for pharmacognosy: https://doi.org/10.1016/j.jdrv.2025.12.008 - The Gut-Skin Axis: Exploring the Role of SCFAs, Obesity, and GLP-1 Receptor Agonists in Atopic Dermatitis: https://jintegrativederm.org/article/view/109 - Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NAD+: https://www.medrxiv.org/content/10.1101/2024.04.17.24305846v1.full-text - Jennifer Fugo information: https://www.skinterrupt.com/book-a-session/ Takeaways - The CDC has approved an ICD 10 code for topical steroid withdrawal. - This approval allows for better study and understanding of TSW. - Diagnostic criteria for TSW are still being developed. - Topical steroid withdrawal may overlap with severe atopic dermatitis. - Non-steroidal treatments are becoming more prominent in dermatology. - Botanicals have been used across cultures for skin treatment. - The gut-skin connection is gaining attention in dermatology. - GLP medications may play a significant role in dermatological treatments. - The future of dermatology is promising with new treatments on the horizon. - A holistic approach to skin health is essential for effective treatment. Chapters 00:00 - Introduction to Dermatology Innovations 01:43 - Topical Steroid Withdrawal Breakthroughs 06:53 - Exploring Botanicals in Dermatology 09:15 - Gut-Skin Connection and Metabolic Health 13:42 - The Role of GLPs in Dermatology 19:42 - Future of Dermatology: Exciting Developments

Dr. Halley Alexadner talks with Dr. Alissa M. D'Gama about genetic testing for infantile epilepsies.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

Pastors don't start cynical or burned out. But somewhere along the way, the wine runs out and we keep preaching, leading, and carrying burdens we were never meant to carry.In a Practically Pastoring Conference session, Tim Wildsmith walks through John 2:1–11 and connects it with Matthew 11:28–30, offering a simple but piercing invitation: name the need, surrender the burden, and pursue soul rest in Jesus before ministry emptiness turns into something worse.Follow Tim Wildsmith:Website: https://timwildsmith.comYouTube: https://www.youtube.com/@timwildsmithInstagram: https://www.instagram.com/timwildsmithX: https://x.com/timwildsmithFacebook: https://www.facebook.com/TimWildsmith/Timestamps:00:00 – Tim's story (Belmont, YouTube, Bible nerd life)03:44 – Why this talk (ministry grind, running on empty)05:42 – Reading: John 2:1–11 (Wedding at Cana)08:02 – When the wine runs out (ministry parallels)10:29 – Mary's model: “They have no more wine” (name the need)12:57 – Burnout realities + overwhelming expectations15:28 – Matthew 11:28–30: where do you go for rest?19:23 – The “rock” exercise: why we don't want to set burdens down22:12 – What is the soul? (Dallas Willard) + “rest for your souls”25:12 – Take His yoke: you can't wear both yokes27:23 – Back to John 2: obedience makes space for Jesus to work29:10 – Production vs. obedience (faithfulness, not self-sufficiency)30:04 – Diagnostic questions: where has the wine run out?32:07 – Practical step: name the need (even hard conversations)36:24 – Prayer for peace, surrender, and courageLinks:

Dr. Nyree Whitley, Chief Clinical Officer at mydentist & Dr. Gordon Barfield, Senior Clinical Manager at Overjet discuss: What a clinician-first diagnostic strategy looks like The dental regulatory & clinical environment in the UK Advice for clinical leaders evaluating AI in dentistry Much more To learn more about Overjet AI you can visit https://www.overjet.com/ and book a demo or connect with Dr. Barfield on Linkedin - https://www.linkedin.com/in/gordon-barfield-dds-ms-676a9516/ To learn more about mydentist you can visit https://www.mydentist.co.uk/ or connect with Dr. Whitley on Linkedin - https://www.linkedin.com/in/nyree-whitley-2a85b85a/  Subscribe to our channel for more episodes and stay updated on the latest DSO news, insights, and events! If you like our podcast, please give us a ⭐⭐⭐⭐⭐ review on iTunes https://apple.co/2Nejsfa and a Thumbs Up on YouTube.  

Dans cet épisode de Cheminements, nous plongeons au cœur de l'urgence absolue : la méningite. Cette infection foudroyante, qui peut toucher n'importe qui sans prévenir, impose une course contre la montre où le diagnostic précoce est la seule clé pour éviter le décès ou des séquelles irréversibles. À travers le récit bouleversant d'une mère devenue présidente d'association et l'expertise d'un infectiologue, nous explorons comment la collaboration entre patients et soignants sauve des vies et comment les nouvelles technologies diagnostiques transforment la prise en charge à l'hôpital.Les intervenants :Patricia Merhant-Sorel : Présidente de l'association Petit Ange (Ensemble contre la méningite). Après avoir perdu sa fille Gwendoline en 2003, elle consacre son action à l'accompagnement des familles et à la sensibilisation du public et des professionnels de santé.Docteur Nicolas Ettahar : Infectiologue au Centre Hospitalier de Valenciennes. Expert de la réalité clinique des maladies infectieuses, il apporte son regard sur les enjeux de diagnostic et de prévention.Les sujets abordés dans l'épisode :Le témoignage de Patricia sur la perte brutale de sa fille et la création de l'association Petit Ange.Les formes fulgurantes de la maladie : pourquoi l'évolution peut être fatale en moins de 12 heures.L'importance capitale du diagnostic différentiel face à des symptômes parfois trompeurs (fièvre, maux de tête).L'apport des tests rapides (PCR) pour cibler immédiatement le bon traitement antibiotique.Le rôle de la vaccination et des mesures barrières dans la prévention collective.La nécessité d'un dialogue permanent entre les familles, les cliniciens et les industriels du diagnostic.Écriture : Marguerite de RodellecProduction : MedShake StudioCet épisode est enregistré dans le cadre de la première édition de la Journée Patients & Pharma, un événement pour créer un véritable espace de dialogue entre représentants de patients et industrie qui aura lieu le 4 décembre 2025, à la Maison A. Trocadéro. Chers auditeurs, je vous informe que cette journée s'écoutera aussi ! Des épisodes exclusifs du podcast Cheminements seront enregistrés en direct, pour donner la parole à des binômes patients / laboratoires qui viendront raconter leurs collaborations, leurs défis, et parfois même… leurs histoires d'amour professionnelles. Alors si ce sujet vous parle, rejoignez-nous.Ressources :https://patientspharma.com/En ouvrant le dictionnaire, on apprend que "cheminement" désigne une progression graduelle, un mouvement, une avance graduelle.➡ Retrouvez tous les épisodes sur https://www.cheminements.co/❤️ Soutenez-nous gratuitement :Abonnez-vous !Laissez 5 étoiles et un avis sur Apple Podcasts ou Spotify ⭐Cheminements, le podcast santé des femmes, dans vos oreilles chaque semaine.Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

What if one of the biggest predictors of falls, balance issues, and even athletic decline wasn't the hips, core, or knees, but the toes? And what if strengthening them could dramatically change outcomes as we age? In this episode, I sit down with Dr. Tom Michaud, a chiropractor, researcher, and internationally recognized expert in foot biomechanics, to explore how weak toes and poor foot function significantly increase fall risk in older adults and limit performance in master athletes. We discuss why foot and ankle health is often overlooked and how it serves as the foundation for balance, speed, and long-term vitality. Dr. Michaud breaks down findings from pivotal studies, including work by researchers like Karen Mickle and Max Piquet, highlighting the role of intrinsic foot muscles such as the flexor hallucis longus and peroneus longus in stability and dynamic movement. We also cover simple at-home tests to assess fall risk and practical exercises that actually improve foot strength. This episode is essential listening for clinicians, athletes, and anyone who wants to stay mobile, resilient, and active as they age.   Key takeaways: Weak toes are a primary predictor of falls in older adults, leading to serious injuries and complications. Enhancing toe strength through targeted exercises can significantly reduce fall risk while boosting athletic performance. Not all traditional foot exercises are effective - exercising the foot muscles in a lengthened position yields better strength gains. Proper assessment of foot architecture and the application of custom strengthening exercises can prevent injuries and improve dynamic performance. Diagnostic tests like the anterior fall envelope and paper grip tests offer valuable insights into an individual's fall risk and foot strength.   More About Dr. Tom Michaud:   In the early nineties, Williams and Wilkins published Dr. Michaud's first textbook, Foot Orthoses and Other Forms of Conservative Foot Care, which was eventually translated into four languages. His next book, Human Locomotion: The Conservative Management of Gait-Related Disorders, which was published in 2012, is used in physical therapy, chiropractic, pedorthic, and podiatry schools around the world. In addition to technical books, Tom also published a book for recreational runners: Injury-Free Running: How to Build Strength, Improve Form, and Treat/Prevent Injuries, now in its second edition. During his 40 years of clinical practice, Dr. Michaud designed and patented numerous diagnostic tools and exercise products to help with the evaluation and treatment of a wide range of sports injuries. Since his recent retirement from clinical practice, Tom is devoting his time to researching, writing, and designing new products in order to develop evidence-based evaluation and treatment protocols that can assist in not just the prevention of sports injuries, but also in ways to stay fit as we age.   Website Instagram Connect with me! Website Instagram Facebook YouTube

"Isolate the Real It: The Diagnostic Approach to Closing More Sales"You didn't lose that sale because of price, product, or timing. You lost it because you never isolated the Real It—the actual thing standing in the way. Most salespeople try to solve everything at once, overwhelming the homeowner and killing the sale before it ever had a chance.In this episode, Sam Wakefield breaks down the diagnostic approach to sales that separates top performers from everyone else. You'll learn how to use qualification questions—not to qualify the homeowner, but to isolate the components of their decision. When you stop guessing and start diagnosing, you close more sales with less resistance.If you've ever walked away from an appointment confused about what went wrong, this episode will show you exactly how to find the Real It and guide your homeowner to clarity. This is the mental shift that changes everything.In This Episode:Why most salespeople lose sales by trying to solve the wrong problemThe combination lock metaphor: how one misaligned piece blocks the entire saleHow to use qualification questions to separate product, payment, timeline, and scopeReal-world language examples of isolating the Real It in appointmentsWhy confidence looks like clarity, not information overloadThe difference between diagnosing and convincingHow to get commitment before you negotiateWhy you can't negotiate with confusion—only clarityResources & Mentions:Win-Win Selling by Doug C. Brown (origin of "the Real It" language)Close It Now Coaching: closeitnow.net/coachingClose It Now Facebook Group: facebook.com/groups/closeitnowEmail Sam: sam@closeitnow.netNew Group Coaching Program:Sam is opening his first group coaching program starting March 2026. Pods of 5 salespeople focused on multiplying close rates and average tickets with integrity. Half the cost of one-on-one coaching. Limited to 5 spots per group. Visit closeitnow.net or email sam@closeitnow.net to learn more.Final Thought:A problem that is well-defined is half-solved. The next time a homeowner hesitates, don't panic. Don't pile on more information. Don't assume what's wrong. Just isolate the Real It. Ask the question that separates the pieces. Find the number that's off on the combination lock. And help them see it clearly. That's when the sale happens.Next Week:How to Right-Size a Project Without Discounting Your Price—the skill that protects your margin while keeping the sale alive.Leave a review on Apple Podcasts or Google to help more salespeople find this show.Google Review Link: https://g.page/r/CbfnnDqTCwQdEAE/review

Eliot Deval revient pendant deux heures, sans concession, sur tous les sujets qui font l'actualité. Vous voulez réagir ? Appelez le 01.80.20.39.21 (numéro non surtaxé) ou rendez-vous sur les réseaux sociaux d'Europe 1 pour livrer votre opinion et débattre sur les grandes thématiques développées dans l'émission du jour.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Tired of watching deals drag on for months while your pipeline stalls and your confidence tanks?Here's the truth most consultants miss: you're the one slowing down your own sales cycle.In this episode, Melisa reveals the four strategies that help consultants close deals faster without discounting, settling, or feeling "salesy."You'll discover why corporate buyers aren't actually the problem (even though it feels that way), and how the delays, stalls, and endless "I'll get back to you” responses are often triggered by how you're showing up in the sales process.This episode dismantles the myth that corporate buyers are always slow and instead puts the focus back on you as the expert, guiding, recommending, and leading your prospects toward clarity and action.Episode Timestamps:[06:01] Why long sales cycles are usually consultant-created and what to do about it[08:23] The Expert Mindset and how certainty speeds up decisions[18:02] The Foot-in-the-Door Offer strategy to generate revenue faster[25:08] How co-creating proposals with your buyer reduces delays and revisions[31:17] The Account Plan and how to stop winging your sales efforts[38:46] 6 questions to self-diagnose where your sales process needs workWhat you'll learn:The hidden consultant behaviors that extend your consulting sales cycle by weeks or even monthsHow to accelerate B2B sales without being pushy or compromising your valuePractical strategies to reduce proposal rework and rescoping delaysHow to lead the buying process with confidence and clarityWhy adopting an expert mindset shortens decision timelinesHow to diagnose and fix weak points in your sales processTopics covered: sales cycle management, consulting business development, B2B sales strategies, client acquisition for consultants, shortening sales timelines, proposal management, consulting sales process, expert positioningStop losing deals to delay. Listen to Episode 256 now and take back control of your sales timeline before another month slips by.Mentioned ResourcesCompanion Resource: Read Chapter 10 in Melisa's book, Grow Your Consulting Business: The 14-Step Roadmap to Make Your Independent Consulting Goals a Reality, https://www.amazon.com/dp/B0CSXJBGVB    Full Show Notes: https://shownotes.melisaliberman.com/episode-256Melisa's Books, Planners & Journals: https://linktr.ee/melisalibermanMentioned in this Episode: Episode 159 - Shorten the Consulting Sales Cycle by Offering a Diagnostic, https://shownotes.melisaliberman.com/episode-159/#more-2340 Want help achieving your consulting business goals? Melisa can help. Click here for more on coaching tailored to you as an independent consulting business owner.

Wayne Broman of Boeck Farm Outfitters has been helping growers with Precision Planting equipment since Cleansweep hit the market. In this episode, he tells Hans and Tyler the story about one of the most difficult troubleshooting scenarios he has come across.

Functional Neurological Disorder (FND) is often misunderstood... but it's real, common, AND treatable. In this episode of Talk Dizzy To Me, vestibular physical therapists Dr. Abbie Ross, PT, NCS and Dr. Carly Lochala, PT, NCS sit down with Dr. Julie Hershberg, PT, NCS to explain what FND is, why it's been minimized in healthcare, and how it overlaps with dizziness, migraine, dysautonomia/POTS, hypermobility/EDS, and vestibular disorders.They break down brain networks like the default mode network and salience network, discuss common clinical clues (variability, attention-related shifts), and explain how treatment often starts with nervous system regulation, trust-building, and whole-person care—not just exercises.If you've been told your symptoms are “all in your head,” this episode is for you.Guest: Dr. Julie Hershberg / Reactive PT Instagram: @reactiveptResources: FND resources hub, reactivept.com/FNDresourcesHosted by:

How can healthcare professionals transform burnout and trauma into a revitalized life and practice?In this special episode of Heartline: Changemaking in Healthcare, Dr. Andrea Austin reads from her book Revitalized, focusing on the chapter "The Revitalization." She reflects on her own soul-level burnout at the end of the pandemic, sharing a formula for change: inflection point + inner work + clarity = revitalization. Drawing from personal experiences and expert insights, she emphasizes embracing the past's pain as part of growth, avoiding trauma loops, and intentionally "doing the work" for self-improvement.You'll hear how to:Recognize burnout as a chronic issue requiring inner reflection, not just quick fixes, and frame it as an opportunity for revitalization beyond "bouncing back."Differentiate top-down therapies (like CBT and talk therapy) from bottom-up approaches (like EMDR, somatic experiencing, and art therapy) for trauma healing, especially in high-stress fields like medicine.Understand coaching as a future-focused partnership for unlocking potential, while knowing when to seek therapy first, given high rates of PTSD (40%) and depression (30%) among healthcare workers.Navigate "VUCA" (volatility, uncertainty, complexity, ambiguity) in healthcare, including life quakes like job loss or health crises, and avoid maladaptive coping like overconsumption or addictions.Build vulnerability in hard conversations, reflect on perfectionism, and beware predatory coaching programs while prioritizing ethical, supportive resources.If you're a healthcare professional grappling with burnout, trauma, or the desire for more fulfillment, this episode offers empathetic guidance, reflective questions, and actionable steps to craft your own revitalization.

In this episode, Dr. Erica Lacher and show host Justin Long talk about the wide variety of diagnostic tools that veterinarians use, what information they provide, and how veterinarians decide the best diagnostic options on a limited budget. Topics include imaging, blood tests, and more!

When your child survives one medical emergency only to face another, parenting becomes a constant act of advocacy and courage. Today's guest joins us to share her daughter's journey with rare and complex medical conditions, from early respiratory failure and unexplained hospitalizations to epilepsy, lung disease, and life with medical uncertainty. As a military spouse navigating deployments, Brittany shares what it means to walk this path largely alone, trust her instincts as a mother, and fight to be believed by medical professionals. This episode explores navigating rare disease without clear answers, the life-changing impact of compassionate child life support, supporting siblings through medical trauma, and how rituals, play, and community help families find hope and meaning in the midst of chaos. Download our free Children's Hospital Passport to help empower your child and family during hospital stays. Sponsored in part by HealthWell Foundation—learn how you can help families afford life-saving medications at healthwellfoundation.org.   Resources from today's episode: Medical Support:  Stanford Children's Health  Undiagnosed Diseases Network Nonprofit & Community Support: Live Like JoJo Foundation The Meg Foundation (Pediatric Pain & Poke Plans)  Brave Bears Club (Epilepsy Support) Child Life Mommy CHYP  Connect with Brittany Follow Brittany's journey as she shares life as a medical mom, military spouse, and advocate.    Connect & Support from Child Life On Call  Subscribe: Never miss an episode on Apple Podcasts or Spotify. Visit insidethechildrenshospital.com to easily search stories and episodes Follow us on Instagram for updates and opportunities to connect with other parents Download SupportSpot: receive Child Life tools at your fingertips. Leave a Review: It helps other families find us and access our resources!   Keywords: Rare disease parenting, Medical motherhood, Medically complex child, Pediatric lung disease, Pediatric epilepsy, Intractable epilepsy, PICU parent experience, Military family healthcare, Parent advocacy in healthcare, Child life specialist support, Sibling support during hospitalization, Parenting after medical trauma, Coping with chronic illness, Undiagnosed disease journey, Hospital parent support Medical information provided is not a substitute for professional advice—please consult your care team  

In this episode of "PICU Doc On Call," Drs. Pradip Kamat and Rahul Damania discuss the acute management of a 14-year-old boy with severe rectal bleeding and hypertension, ultimately diagnosed with inflammatory bowel disease (IBD). They review the approach to pediatric lower GI bleeding, diagnostic workup, and imaging, emphasizing early recognition and resuscitation. They outline IBD management, including steroids, biologics such as infliximab, and nutritional support, while highlighting the importance of screening for infections before immunosuppression. The episode provides practical insights for PICU physicians on handling acute GI emergencies in children.Show Nighlights: Clinical case of a 14-year-old male with hypertension and rectal bleeding.Diagnosis of inflammatory bowel disease (IBD) following significant blood loss.Approach to pediatric rectal bleeding and its implications.Diagnostic workup including laboratory tests and imaging modalities.Management strategies for IBD in acute pediatric care.Importance of early recognition and resuscitation in cases of shock.Physiological principles related to blood loss and shock in children.Differential diagnoses for lower gastrointestinal bleeding in pediatrics.Initial evaluation and stabilization protocols for pediatric patients.Nutritional support and multidisciplinary care in managing IBD. References:Romano C, Oliva S, Martellossi S, et al. Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. World J Gastroenterol. 2017;23(8):1326-1337.Pai AK, Fox VL. Gastrointestinal bleeding and management. Pediatr Clin North Am. 2017;64(3):543-561.Padilla BE, Moses W. Lower gastrointestinal bleeding and intussusception. Surg Clin North Am. 2017;97(1):63-80.Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT. Inpatient management of inflammatory bowel disease-related complications. Clin Gastroenterol Hepatol. 2020;18(11):2417-2428.Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. Lancet Child Adolesc Health. 2017;1(2):147-158.Bouhuys M, Lexmond WS, van Rheenen PF. Pediatric inflammatory bowel disease. Pediatrics. 2022;150(6):e2022059341.Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr. 2015;169(11):1053-1060.Conrad MA, Rosh JR. Pediatric Inflammatory Bowel Disease. Pediatr Clin North Am. 2017 Jun;64(3):577-591.